Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

A Non-Inferiority Study of Combination of Latanoprost and Timolol Formulation to Their Separate Use in Drug-Naive Primary Open Angle Glaucoma and Ocular Hypertension Nigerian Patients. {RCT 93803536 (Nigeria Clinical Trial Registry)}.

2023PubMedJournal

0 citations

Authors

6 authors across 3 institutions in 1 country.

O P AbikoyeFirst author
- Federal Medical Centre (NG)
O O Abesin
- Federal Medical Centre (NG)
Oluwatoni Olaide Onabolu
- Olabisi Onabanjo University Teaching Hospital (NG)
as printed: O O Onabolu
Haroun Adetunji Ajibode
- Olabisi Onabanjo University Teaching Hospital (NG)
as printed: H A Ajibode
Feyi Adepoju
- University of Ilorin Teaching Hospital (NG)
as printed: F G Adepoju
R O MusibauSenior author
- Federal Medical Centre (NG)

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Glaucoma and retinal disorderslevel 3 · 0.99
Retinal Diseases and Treatmentslevel 3 · 0.00
Intraocular Surgery and Lenseslevel 3 · 0.00

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2023 · PubMed · 0 citations
https://openalex.org/W4391144967

A Non-Inferiority Study of Combination of Latanoprost and Timolol Formulation to Their Separate Use in Drug-Naive Primary Open Angle Glaucoma and Ocular Hypertension Nigerian Patients. {RCT 93803536 (Nigeria Clinical Trial Registry)}. · Sankore